Acikgoz, Y. et al. (2019) “The Difference in Clinical and Prognostic Features Between De Novo and Recurrent Her2-Positive Metastatic Breast Cancer Patients: Her2-positive metastatic breast cancer patients”, Acta Medica, 50(4), pp. 14–19. doi:10.32552/2019.ActaMedica.395.